Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001831942-25-000007·Cidara Therapeutics, Inc.
Schedule 13G ownership disclosure
CIDARA THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 171757206
Event date: 2025-06-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commodore Capital LP
Shares: 1,175,000.00 · Class: 5.5%
- Commodore Capital Master LP
Shares: 1,175,000.00 · Class: 5.5%
- Robert Egen Atkinson
Shares: 1,175,000.00 · Class: 5.5%
- Michael Kramarz
Shares: 1,175,000.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001831942-25-000007
- Form type
- SCHEDULE 13G
- Filer
- Cidara Therapeutics, Inc.
- CIK
- CIK 1610618
- Filed
- Jul 02, 2025
- Reporting period
- Jun 25, 2025
- Description
- Schedule 13G beneficial ownership